Analyst Research Report Snapshot

Title:

Aastrom Biosciences, Inc.

Price:

$50.00

Provider:

MarketLine (a Datamonitor Company)

Date:

28 Aug 2013

Pages:

36

Type:

AcrobatPDF

Companies referenced:

ASTM.OQ

Available for Immediate Download
Summary:

Aastrom Biosciences, Inc. - Company Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, product and service offerings, and corporate actions, providing a 360° view of the company. Features: - Detailed information on Aastrom Biosciences, Inc. required for business and competitor intelligence needs - Intelligence on Aastrom Biosciences, Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors - News about Aastrom Biosciences, Inc., such as business expansion, restructuring, and contract wins - Large number of easy-to-grasp charts and graphs that present important data and key trends Highlights: Aastrom Biosciences (Aastrom) is engaged in developing patient-specific, expanded multicellular therapies for use in the treatment of patients with severe, chronic cardiovascular diseases. The company's proprietary cell-processing technology enables the manufacture of ixmyelocel-T, a patient-specific multicellular therapy expanded from a patient's own bone marrow and delivered directly to damaged tissues. Aastrom has advanced ixmyelocel-T into late-stage clinical development, including a Phase 2b clinical trial in patients with ischemic dilated cardiomyopathy. The company primarily operates in the US, where it is headquartered in Ann Arbor, Michigan, and employs 77 around people. The company recorded revenues of $21 thousand in the fiscal year ended December 2012, an increase of 16.7% over 2011. The company's operating loss was $33,760 thousand in fiscal 2012, as compared to an operating loss of $29,040 thousand in 2011. Its net loss was $33,467 thousand in fiscal 2012, as compared to the net loss of $19,668 thousand in 2011. Reasons to Purchase: - Gain understanding of Aastrom Biosciences, Inc. the company and its strategies - Track strategic initiatives of the company and latest corporate news and actions - Assess Aastrom Biosciences, Inc. as a prospective partner, vendor or supplier - Support sales activities by understanding your customers' businesses better - Stay up to date on Aastrom Biosciences, Inc. your competitors' business structure, strategy and prospects

Why buy analyst research?

  • Institutional quality research
  • Available for Immediate Download
  • Detailed company or industry insight
  • Print or save
  • 24 hour customer support
Return to previous page without adding this item to your cart.
Email Customer Support.

About Analyst Research

Analyst research reports are available for immediate download after purchase. You will have unlimited access to the report for 24 hours after purchase, to download, print or save it as many times as you wish. Analyst Research provided by Reuters does not constitute investment advice, and is not endorsed by Reuters Research. This information is protected by copyright and intellectual property laws. More information on Analyst Research.